BridgeMD
New treatment option for Neonatal Sepsis
Official title Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated Infection
ClinicalTrials.gov ID: NCT07421323
What this study is testing
What is Alcohol hand rub group?
Alcohol hand rub group is an investigational medicine, being studied as a potential treatment for neonatal sepsis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to compare of effect of chlorhexidine gluconate and alcohol hand rubbing on healthcare-associated infection (HCAI) in neonatal intensive care unit at Alexandria University Children Hospital.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 1
You may be able to join if
- Neonates \<37 weeks gestational age admitted to NICU of Alexandria University Children's Hospitals
You likely can't join if
- Patients with any of the following will be excluded:
- Obvious major congenital abnormalities, immunodeficiency and inborn error of metabolism.
- Early onset sepsis (before the third day).
- Infants more than 72 hours of age at the time of randomization.
- Parental consent lacking/refusal.
The study team makes the final eligibility decision.
Where it's taking place
- Alexandria, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 hours to 1 day. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alexandria, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.